Device evaluation of monitor (b)(4) and electrode belt (b)(4) has been completed.The evaluation included review of downloaded software flag files on the day of the event and incoming functional testing.During the incoming functional testing, a 1hz simulated normal sinus rhythm signal was applied to the ecg electrodes, followed by a 5hz simulated treatable arrhythmia signal which verified proper performance of the detection algorithm.During the transition to the 5hz signal, the device was confirmed to properly enter into a treatment sequence which includes a verification of the tactile vibration alarm, audio messaging, and siren alarms, as well as a test of the pulse delivery circuitry.The pulse delivery circuitry test verified proper charging of the high voltage capacitors and proper delivery of five full energy 150j biphasic pulses.The functional testing confirmed proper response button functionality, ecg acquisition, detection algorithm performance, and pulse delivery functionality.There is no indication of a product malfunction.Device manufacture date: monitor 04/07/2014.Belt 04/24/2018.
|
A us distributor contacted zoll to report that a patient passed away while wearing the lifevest on (b)(6) 2021.It was reported that ems was called and performed resuscitation efforts on the patient.Per clinical review of the continuous ecg recording, the device was started up at 09:37:18 on (b)(6) 2021.The device was shutdown at 08:23:29 on (b)(6) 2021 while the patient was in sinus tachycardia at 120 bpm.The device was started up again at 08:49:07.The patient was in svt at 170 bpm with nsvt at 10:34:27.The patient's rhythm transitioned to vt at 270 bpm at 10:35:00.The device was shutdown at 10:35:07.The lifevest detected the vt arrhythmia, but the device was shut down before a shock could be delivered.It was not reported who shut down the device.
|